Silver Book Fact

MRSA infections increase in older patients

In 2008, 75% of healthcare-associated invasive MRSA infections occurred in patients older than 50, with 46% in patients older than 65%.

Kallen, Alexander J., Yi Mu, Sandra Bulens, Arthur Reingold, Susan Petit, Ken Gershman, Susan M. Ray, Lee H. Harrison, Ruth Lynfield, Ghinwa Dumyati, John M. Townes, William Schaffner, Priti R. Patel, Scott K. Fridkin; for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Healthcare-Associated Invasive MRSA Infections, 2005-2008. JAMA. 2010; 304(6): 641-7. http://jama.jamanetwork.com/article.aspx?articleid=186385

Reference

Title
Healthcare-Associated Invasive MRSA Infections, 2005-2008
Publication
JAMA
Publication Date
2010
Authors
Kallen, Alexander J., Yi Mu, Sandra Bulens, Arthur Reingold, Susan Petit, Ken Gershman, Susan M. Ray, Lee H. Harrison, Ruth Lynfield, Ghinwa Dumyati, John M. Townes, William Schaffner, Priti R. Patel, Scott K. Fridkin; for the Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program
Volume & Issue
Volume 304, Issue 6
Pages
641-7
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • ~70% of hospital HAIs resistant to ≥ antimicrobial
    Approximately 70% of hospital-acquired HAIs are resistant to at least one antimicrobial drug.  
  • Around $35 billion cost to society from antibiotic resistant infections
    The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.  
  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • HAIs cost patients additional $43,000 per hospital stay
    Patients with HAIs cost, on average, $43,000 more per hospital stay than those without an infection ($52,096 vs. $9,377).  
  • Comorbidities and hospitalization higher with HAIs
    Patients with HAIs have more comorbidities (2.8 vs. 1.9) and in-hospital mortality (9% vs. 1.5%), compared to all other hospitalized patients.